Role of Enterocyte Enpp2 and Autotaxin in Regulating Lipopolysaccharide Levels, Systemic Inflammation and Atherosclerosis

By sjmartinez • April 15, 2023

Chattopadhyay A, Mukherjee P, Sulaiman D, Wang H, Girjalva V, Dorreh N, Jacobs JP, Delk S, Moolenaar WH, Navab M, Reddy ST, Fogelman AM. Role of Enterocyte Enpp2 and Autotaxin in Regulating Lipopolysaccharide Levels, Systemic Inflammation and Atherosclerosis. J Lipid Res. 2023 Apr 12:100370. doi: 10.1016/j.jlr.2023.100370. Epub ahead of print. PMID: 37059333.

Tags: Apolipoprotein A-I (apoA-I) mimetic peptides, Atherosclerosis, Cardiology/Epi, Digestive Diseases, Lysophosphatidic acid (LPA), Lysophospholipase D, Oxidized phospholipids, Publications, Small intestine, Transgenic tomatoes expressing the apoA-I mimetic peptide 6F (Tg6F)

Implementing a Cardiology Quality Incentive Program to Improve Guideline-Directed Medical Therapy

Cho DJ, Bokhoor PI, Dermenchyan A, Brownell N, Delavin NL, Furlong S, Hoo J, Tibbe T, Chen LY, Vangala S, Waterman BA, Han M, Fonarow[...]

Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy

Juarez Casillas JE, Nikitas J, Rettig MB, Reiter RE, Lee A, Steinberg ML, Valle L, Kalbasi TR, Calais J, Czernin J, Eala MA, Tsai S,[...]

Towards accurate interpretation of hypothesis testing in cardiology randomised controlled clinical trials

Sharifan A, Fonarow G. Towards accurate interpretation of hypothesis testing in cardiology randomised controlled clinical trials. Heart. 2025 Jun 20:heartjnl-2025-326515. doi: 10.1136/heartjnl-2025-326515. Epub ahead of[...]